Ecuador vs Montenegro: HIV-positive TB patients on ART (antiretroviral therapy)
Ecuador
100.0%
in 2024
Montenegro
100.0%
in 2023
Ecuador rank
1st
Montenegro rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Ecuador
- Montenegro
How they compare
Ecuador currently reports 100.0% against 100.0% in Montenegro, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2010 it was Montenegro ahead.
Ecuador ranks 1st and Montenegro ranks 1st of 144 countries.
Across the 2 decades both report, Ecuador averaged higher in 1 and Montenegro in 1.
Head to head by decade
| Decade | Ecuador | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.7% | 100.0% | 4.3% | Montenegro |
| 2020s | 91.0% | 75.0% | 16.0% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Ecuador or Montenegro?
- Ecuador, at 100.0% against 100.0% in Montenegro as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Ecuador and Montenegro?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Montenegro?
- 5 years are reported by both, from 2010 to 2023.
- How do Ecuador and Montenegro rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Ecuador ranks 1st and Montenegro ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.